The oral iron chelator deferasirox might improve survival in allogeneic hematopoietic cell transplant (alloHSCT) recipients with transfusional iron overload

✍ Scribed by Sivgin, Serdar; Baldane, Suleyman; Akyol, Gulsah; Keklik, Muzaffer; Kaynar, Leylagül; Kurnaz, Fatih; Pala, Cigdem; Zararsiz, Gokmen; Cetin, Mustafa; Eser, Bulent; Unal, Ali

• Book ID: 122344875
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 449 KB
• Volume: 49
• Category: Article
• ISSN: 1473-0502
• DOI: 10.1016/j.transci.2013.07.004